Medicine and Dentistry
Patient
100%
Enzyme Replacement Therapy
72%
Glycogen Storage Disease Type II
72%
Lung Function
36%
Muscle Function
27%
Diseases
18%
Adverse Event
18%
Early Diagnosis
18%
Enzyme
9%
Follow up
9%
Deterioration
9%
Disease Course
9%
Autosomal Recessive Disorder
9%
Motor Performance
9%
Anaphylaxis
9%
Evaluation Study
9%
Glucan 1,4 Alpha Glucosidase
9%
Alpha Glucosidase
9%
Laboratory
9%
Pharmacology, Toxicology and Pharmaceutical Science
Glycogen Storage Disease Type 2
72%
Clinical Study
27%
Diseases
18%
Adverse Event
18%
Enzyme
9%
Glucan 1,4 Alpha Glucosidase
9%
Alpha Glucosidase
9%
Prognosis
9%
Anaphylaxis
9%
Deterioration
9%
Disease Course
9%
Biochemistry, Genetics and Molecular Biology
Lysozyme
81%
Lung Function
36%
Muscle Function
27%
Acid Alpha-Glucosidase
9%
Alpha-Glucosidase
9%